Amicus Therapeutics Inc (FOLD) Insider Trading
- $71,123,425.77
- $145,122,652.45
- Nov. 6, 2024
- John F Crowley
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 1, 2020 | CFO | 5,000 | $14.02 | Sell | $70,100.00 | |
Oct. 1, 2020 | Director | 1,500 | $14.28 | Buy | $21,420.00 | |
Sept. 28, 2020 | COO | 24,782 | $13.89 | Sell | $344,221.98 | |
Sept. 1, 2020 | Director | 1,500 | $14.62 | Buy | $21,930.00 | |
Sept. 1, 2020 | CEO | 29,900 | $14.18 | Sell | $423,982.00 | |
Aug. 31, 2020 | Insider | 28,750 | $14.74 | Sell | $423,775.00 | |
Aug. 17, 2020 | CEO | 20,000 | $14.89 | Sell | $297,800.00 | |
Aug. 5, 2020 | Insider | 198 | $15.05 | Sell | $2,979.90 | |
July 27, 2020 | Insider | 30,000 | $15.05 | Sell | $451,500.00 | |
July 16, 2020 | Insider | 30,000 | $15.26 | Sell | $457,800.00 | |
July 15, 2020 | CEO | 20,000 | $15.54 | Sell | $310,800.00 | |
July 9, 2020 | Insider | 44,447 | $15.92 | Sell | $707,596.24 | |
July 8, 2020 | COO | 2,500 | $16.01 | Sell | $40,025.00 | |
July 7, 2020 | Insider | 178,988 | $15.90 | Sell | $2,845,909.20 | |
July 2, 2020 | Insider | 198 | $15.80 | Sell | $3,128.40 | |
July 1, 2020 | CFO | 6,872 | $15.47 | Sell | $106,309.84 | |
July 1, 2020 | CEO | 39,655 | $15.48 | Sell | $613,859.40 | |
July 1, 2020 | Director | 1,500 | $15.20 | Buy | $22,800.00 | |
July 1, 2020 | COO | 12,500 | $15.47 | Sell | $193,375.00 | |
June 29, 2020 | Insider | 30,000 | $15.51 | Sell | $465,300.00 | |
June 19, 2020 | Insider | 3,366 | $15.00 | Sell | $50,490.00 | |
June 17, 2020 | Insider | 1,904 | $13.47 | Sell | $25,646.88 | |
June 15, 2020 | CEO | 20,000 | $10.88 | Sell | $217,600.00 | |
June 1, 2020 | Director | 5,000 | $12.65 | Sell | $63,250.00 | |
June 1, 2020 | COO | 17,502 | $12.66 | Sell | $221,575.32 | |
June 1, 2020 | CEO | 9,755 | $12.66 | Sell | $123,498.30 | |
May 26, 2020 | COO | 2,500 | $13.01 | Sell | $32,525.00 | |
May 15, 2020 | CEO | 20,000 | $11.44 | Sell | $228,800.00 | |
May 1, 2020 | CEO | 9,755 | $11.32 | Sell | $110,426.60 | |
May 1, 2020 | COO | 17,503 | $11.33 | Sell | $198,308.99 | |
April 17, 2020 | Director | 10,000 | $11.00 | Sell | $110,000.00 | |
April 15, 2020 | CEO | 20,000 | $9.92 | Sell | $198,400.00 | |
April 7, 2020 | COO | 2,500 | $10.12 | Sell | $25,300.00 | |
April 1, 2020 | COO | 15,003 | $9.09 | Sell | $136,377.27 | |
April 1, 2020 | CEO | 9,755 | $9.08 | Sell | $88,575.40 | |
March 20, 2020 | CEO | 20,000 | $9.00 | Sell | $180,000.00 | |
March 5, 2020 | COO | 2,500 | $10.01 | Sell | $25,025.00 | |
March 2, 2020 | CEO | 9,755 | $9.10 | Sell | $88,770.50 | |
Feb. 5, 2020 | COO | 2,500 | $10.01 | Sell | $25,025.00 | |
Feb. 3, 2020 | COO | 15,003 | $8.91 | Sell | $133,676.73 | |
Feb. 3, 2020 | CEO | 9,754 | $8.91 | Sell | $86,908.14 | |
Jan. 15, 2020 | Insider | 22,100 | $10.35 | Sell | $228,735.00 | |
Jan. 15, 2020 | COO | 5,064 | $10.35 | Sell | $52,412.40 | |
Jan. 15, 2020 | CEO | 100,000 | $10.35 | Sell | $1,035,000.00 | |
Jan. 9, 2020 | Director | 20,000 | $10.00 | Sell | $200,000.00 | |
Jan. 9, 2020 | CFO | 15,000 | $9.93 | Sell | $148,950.00 | |
Jan. 9, 2020 | COO | 2,500 | $10.01 | Sell | $25,025.00 | |
Jan. 6, 2020 | Insider | 6,836 | $9.28 | Sell | $63,438.08 | |
Jan. 2, 2020 | COO | 22,127 | $9.58 | Sell | $211,976.66 | |
Jan. 2, 2020 | Insider | 9,753 | $9.55 | Sell | $93,141.15 |
Insiders are both buying and selling Amicus Therapeutics Inc stock.
The insider traders at Amicus Therapeutics Inc are: John F Crowley, Bradley L Campbell, Jay Barth, Hung Do, Burke W Whitman, Daphne Quimi, William D Baird III, Perceptive Advisors Llc, Ellen Rosenberg, Jeff Castelli, Samantha Prout, Margaret G Mcglynn, Michael Raab, David Michael Clark, Life Sciences Maste Perceptive, Kenneth Peist, Jayne Gershkowitz, Glenn Sblendorio, Julie Yu, Donald J Hayden Jr, Kurt J Andrews, Plc Glaxosmithkline, Ken Valenzano, Bradley L. Campbell, Enrique Dilone, William D. Baird III, Burke W. Whitman, Dipal Doshi, Joan Winterbottom, John F. Crowley, Lynn Dorsey Bleil, and Sol J Barer
The most active insider trader at Amicus Therapeutics Inc is John F Crowley with 110 trades.
Plc Glaxosmithkline has sold the most Amicus Therapeutics Inc stock with a total value of $119,721,428.50.
Perceptive Advisors Llc has bought the most Amicus Therapeutics Inc stock with a total value of $40,474,740.62.
The most recent insider trade for Amicus Therapeutics Inc was on Nov. 6, 2024.
The single biggest insider buy for Amicus Therapeutics Inc was from Life Sciences Maste Perceptive with a total value of $18,375,000.00 on July 13, 2017.
The single biggest insider sell for Amicus Therapeutics Inc was from Plc Glaxosmithkline with a total value of $59,860,714.25 on Oct. 27, 2014.